Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
henry f's Profile
Displaying 151-200 of 503 result(s).
CYDY CytoDyn Inc
05/18/2021 4:49:36 PM
The call is going about as well as (6)
CYDY CytoDyn Inc
05/11/2021 10:23:04 PM
It’s hard to believe that’s eve (3)
CYDY CytoDyn Inc
05/11/2021 5:37:15 PM
Wouldn’t a PO be material news th (3)
CYDY CytoDyn Inc
05/08/2021 12:37:59 PM
Jeff and I may have to split the bo
CYDY CytoDyn Inc
05/07/2021 10:36:38 AM
It’s hard to say. 350k were borro (2)
CYDY CytoDyn Inc
05/05/2021 4:16:46 PM
Once-per-month HIV PReP trial start (1)
CYDY CytoDyn Inc
05/05/2021 4:10:01 PM
Revenue starting next week?! (3)
CYDY CytoDyn Inc
05/03/2021 8:04:11 PM
“HIV expecting full FDA approval
CYDY CytoDyn Inc
04/28/2021 10:40:06 PM
“Fife is obliterating the SP with (6)
CYDY CytoDyn Inc
04/28/2021 10:31:23 PM
Come on, man. You don’t need a p- (4)
CYDY CytoDyn Inc
04/28/2021 10:17:47 PM
I’ve been saying this for months: (4)
CYDY CytoDyn Inc
04/19/2021 4:32:13 PM
Always plenty of coincidences when (4)
CYDY CytoDyn Inc
04/19/2021 1:40:18 AM
Leronlimab has always been given in (6)
CYDY CytoDyn Inc
04/10/2021 11:21:03 PM
The physician’s comments about le (16)
CYDY CytoDyn Inc
04/08/2021 12:30:59 PM
Exactly. Investors haven’t lost a (3)
CYDY CytoDyn Inc
04/08/2021 10:12:20 AM
Your comments show a lack of market (4)
CYDY CytoDyn Inc
04/07/2021 4:21:59 PM
NP mumbled his way through the Mahb (1)
CYDY CytoDyn Inc
03/29/2021 10:03:28 PM
“The only way this pandemic stops (3)
CYDY CytoDyn Inc
03/07/2021 5:59:27 PM
I agree about the pumping. But I do
CYDY CytoDyn Inc
03/06/2021 10:17:46 PM
My point was that this subset proba
CYDY CytoDyn Inc
03/06/2021 7:33:07 PM
I’m not convinced that this is r (1)
CYDY CytoDyn Inc
03/06/2021 4:23:35 PM
Maybe you learned how to count card (1)
CYDY CytoDyn Inc
03/06/2021 3:55:18 PM
You said you have been in this stoc (7)
CYDY CytoDyn Inc
03/06/2021 3:44:30 PM
However I feel on Monday, I won’t (4)
CYDY CytoDyn Inc
03/06/2021 3:22:03 PM
Some read the literature. Some list (8)
CYDY CytoDyn Inc
03/06/2021 3:10:02 PM
Frankly, you don’t sound like the
CYDY CytoDyn Inc
03/06/2021 2:34:04 PM
The whole “sticking it shorty” (6)
CYDY CytoDyn Inc
02/28/2021 7:01:20 PM
“The important thing, as I see it (4)
CYDY CytoDyn Inc
02/26/2021 3:30:55 PM
I’ve been keeping my opinion to m (8)
CYDY CytoDyn Inc
02/26/2021 11:58:19 AM
This would be more persuasive if Na (4)
CYDY CytoDyn Inc
02/24/2021 1:23:06 PM
ChessMaster is Michael Sheik. He is (2)
CYDY CytoDyn Inc
02/23/2021 4:53:39 PM
Respect (4)
CYDY CytoDyn Inc
02/16/2021 8:42:59 PM
I remember the good old days when p (11)
CYDY CytoDyn Inc
02/07/2021 1:38:42 AM
“he has taken significant steps t (4)
CYDY CytoDyn Inc
01/07/2021 11:45:21 PM
“CYDY’s goal appears to have be
CYDY CytoDyn Inc
01/07/2021 8:41:13 PM
I always say the same thing. They c (6)
CYDY CytoDyn Inc
01/06/2021 4:46:33 PM
30% total mortality would seem to b
CYDY CytoDyn Inc
01/06/2021 4:42:46 PM
87 deaths so far in CD12.
CYDY CytoDyn Inc
01/06/2021 4:40:45 PM
Clear path forward for NASDAQ. Bigg (1)
CYDY CytoDyn Inc
01/06/2021 4:35:08 PM
Cancer data is strong enough that t (3)
CYDY CytoDyn Inc
01/06/2021 4:32:38 PM
First NASH patient already injected (1)
CYDY CytoDyn Inc
01/06/2021 4:27:38 PM
Signing new agreements for more pro (2)
CYDY CytoDyn Inc
01/06/2021 4:24:39 PM
HIV BLA (combo) on track for submis
CYDY CytoDyn Inc
12/30/2020 7:53:59 PM
The problem is that this board isn (1)
CYDY CytoDyn Inc
12/28/2020 1:57:57 PM
Like i said on another board about (5)
CYDY CytoDyn Inc
12/22/2020 11:07:05 PM
This should be the response to ever (1)
CYDY CytoDyn Inc
12/18/2020 8:31:20 PM
The chat boards are all filled with (5)
CYDY CytoDyn Inc
12/10/2020 5:28:32 PM
I would say that was a pretty good (5)
CYDY CytoDyn Inc
12/10/2020 4:52:35 PM
NP had no comment about the new dru (8)
CYDY CytoDyn Inc
12/10/2020 4:26:42 PM
CD-12 update: -371 patients -5-6 pa (20)
Go to page:
  • << First
  • < Previous
  • 3
  • 4
  • Next >

Recent Articles

  • Farmhouse at Descanso Gardens Set to Launch Innovative Dining
  • M S International, Inc. Unveils Norfolk Distribution Hub
  • Essential Grilling Tips for a Memorable Summer Cookout
  • Magnera Corporation to Engage Investors at Upcoming Conference
  • Yardi's David Bellew Joins Argentum Board to Foster Growth
  • MobileX Partners with Rahal Letterman for Indy 500 Excitement
  • 2025 Affordable Housing Forum to Foster Local Collaboration
  • Strategic Merger to Propel Digital Transformation Efforts
  • Important Update for Solaris Energy Infrastructure Investors
  • PG&E Advises Graduates on Safe Balloon Celebrations
  • Liquidia Introduces YUTREPIA for Pulmonary Hypertension Management
  • MindHYVE.ai™ Leads AI Revolution at Africa's Tech Summit
  • Celebrating Champions in Women’s Health at a Landmark Event
  • Gérard Bertrand Wines Shine at Prestigious Charity Gala Event
  • Kent Lake Urges Quanterix Board to Prioritize Shareholder Value
  • Investing in SoundHound AI: What Investors Need to Know
  • Unlocking the Future of Profit with MiningCoop's Plans
  • Banco Comercial Português Shares Insights on Buy-Back Program
  • Zscaler Leads Gartner's Magic Quadrant for Security Service Edge
  • Malaga Financial Corporation Declares Consistent Quarterly Dividend
  • How Dental Success Network is Tackling Rising Treatment Costs
  • Klear.ai Revolutionizes School Risk Management with AI
  • ISS Endorses Dynavax’s Director Nominees for Stockholders' Voting
  • MindHYVE.ai™ Showcasing AI Innovations at Africa's Tech Event
  • Celltrion's YUFLYMA Achieves FDA Interchangeability Expansion
  • Innovative Transportation Technology Center Set to Open Soon
  • Veterinary Diagnostics Market Growth Forecast Billions by 2029
  • Insights into Constellation Brands' Upcoming Deutsche Bank Conference
  • Quadient SA Invites Shareholders to Upcoming General Meeting
  • Understanding the Surge of E-Bike Injuries Among All Riders
  • Discover Unique Animal Adaptations at Extreme Animals Alive Exhibit
  • Greenland Resources' Annual Meeting Results Highlight Director Support
  • Enhancing Ankle Arthritis Care Through New Training Initiative
  • MediPharm Labs Highlights Governance Issues Surrounding Check-Cap
  • Eimskip Announces Suspension of Case Against Alcoa Fjarðaál
  • Reitir Announces Recent Share Buyback Activities and Strategy
  • Empowering Organizations to Respond Effectively to Crises
  • Celebrating Safety Culture: Gray's Commitment in Construction
  • Global Leaders Unite to Advance Drug Development Strategies
  • Revitalizing Everyday Sound: viaim's Collaboration with Orchestra
  • MySmile Unveils 20% Off Summer Sale and New Whitening Strips
  • A Magical Night of Style: Azazie's Enchanting Fashion Ball
  • Celebrate Innovation This Memorial Day with Monport's Sale
  • Effortless Bitcoin Mining: Your Path to Passive Income with FioBit
  • Nimanode's $NMA Token Presale: Embrace AI on the XRP Ledger
  • Artlanta Partners with TASS HUB to Revolutionize Creative Ownership
  • Oakcreek Golf & Turf Strengthens Portfolio with Key Acquisition
  • Forces Unite in Cleveland to Advance Global Healthcare Solutions
  • Octopus AIM VCT 2 plc Annual Meeting Results Revealed
  • Insight Into Octopus Apollo VCT’s Recent Share Buyback Strategy
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site